Investigations of EGFR configurations on tumor cell surface by high-resolution electron microscopy

Li Wang1, Jintao Li2, Na Zhang2

  • 1Beijing Key Laboratory of Microstructure and Properties of Solids, Institute of Microstructure and Property of Advanced Materials, Beijing University of Technology, Beijing, 100124, China.

Insights

High-resolution electron microscopy visualized Epidermal Growth Factor Receptor (EGFR) configurations on triple-negative breast cancer cells. This imaging technique provides direct evidence of EGFR structure, aiding tumor therapy development.

Area of Science:

  • Biophysics
  • Cancer Biology
  • Nanotechnology

Background:

  • Epidermal growth factor receptor (EGFR) is a key target in cancer therapy.
  • Current knowledge of cell surface EGFR conformations relies on indirect methods.
  • Triple-negative breast cancer (TNBC) presents unique therapeutic challenges.

Purpose of the Study:

  • To visualize individual Epidermal Growth Factor Receptor (EGFR) molecules and their assemblies on TNBC cells.
  • To propose structural models and conformational transitions of EGFR oligomers.
  • To demonstrate the utility of high-resolution electron microscopy for studying cell surface receptors.

Main Methods:

  • Sub-nanometer resolution scanning electron microscopy (SEM) and transmission electron microscopy (TEM).
  • One-to-one labeling of EGFR with gold nanoparticles for enhanced visualization.
  • Analysis of EGFR configurations and oligomerization on TNBC cell surfaces.

Main Results:

  • Direct visualization of individual EGFR molecules and their detailed assembly on TNBC cell surfaces.
  • Proposed novel configurations, structural models, and conformational transitions of EGFR oligomers.
  • Demonstrated the capability of SEM and TEM to resolve molecular details of cell surface receptors.

Conclusions:

  • High-resolution electron imaging offers direct evidence of EGFR configuration on tumor cells.
  • This technique is invaluable for understanding EGFR-associated signaling pathways.
  • The findings may significantly advance the development of targeted EGFR-based tumor therapies.